Status:
UNKNOWN
Statin Intolerance in Patients With Myocardial Infarction
Lead Sponsor:
Turkish Society of Cardiology
Conditions:
Statin Adverse Reaction
Eligibility:
All Genders
18+ years
Brief Summary
Patients with acute coronary syndrome (MI, NSTEMI, USAP) will be included. They will be screened for statin intolernace for 6 months.
Eligibility Criteria
Inclusion
- Acute coronary syndrome
Exclusion
- Being on statin, having statin related side effects
Key Trial Info
Start Date :
August 26 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2020
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04069598
Start Date
August 26 2019
End Date
March 31 2020
Last Update
September 12 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Haseki
Istanbul, Turkey (Türkiye)
2
Siyami Ersek
Istanbul, Turkey (Türkiye)
3
Tepecik
Izmir, Turkey (Türkiye)
4
Ozcan Basaran
Muğla, Turkey (Türkiye), 48000